Select Language
Free Registration

LYPD3

LYPD3 Overview

English NameLy6/PLAUR domain-containing protein 3Approved Drugs0
Drugs in Clinical Trials1Target SynonymC4.4A，GPI-Anchored Metastasis-Associated Protein Homolog，2310061G07Rik，GPI-Anchored Metastasis-Associated Protein C4.4A Homolog，MIG-C4，UNQ491/PRO1007，Ly6/PLAUR domain-containing protein 3，LYPD3，Matrigel-Induced Gene C4 Protein，LY6/PLAUR Domain Containing 3
Highest Development StagePhase 1 Clinical
English NameLy6/PLAUR domain-containing protein 3
Target SynonymC4.4A，GPI-Anchored Metastasis-Associated Protein Homolog，2310061G07Rik，GPI-Anchored Metastasis-Associated Protein C4.4A Homolog，MIG-C4，UNQ491/PRO1007，Ly6/PLAUR domain-containing protein 3，LYPD3，Matrigel-Induced Gene C4 Protein，LY6/PLAUR Domain Containing 3
Approved Drugs0
Drugs in Clinical Trials1
Highest Development StagePhase 1 Clinical

LYPD3 Product List

  • Product Category

    Protein (1)

  • Product Status

    Launched (1)

  • Species

    Human (1)

  • Tag

    His Tag (1)

  • Conjugate

    Unconjugated (1)

Total: 1
  • 1

LYPD3 Background

Ly6/PLAUR domain-containing protein 3 (LYPD3) is also known as MIG-C4 ,C4.4A, GPI-anchored metastasis-associated protein C4.4A homolog and Matrigel-induced gene C4 protein,which is a cell membrane protein containing two UPAR/Ly6 domains. LYPD3 is expressed in placenta, skin and urothelium. LYPD3 is found in the majority of primary and metastatic transitional cell carcinomas (TCCs) and as well in breast cancer tissues, but not in adjacent normal tissues. LYPD3 play a role in supporting cell migration and it is not only probably involved in urothelial cell-matrix interactions, but also in tumor progression.

LYPD3 Synonyms

LYPD3,MIG-C4,C4.4A
  • Overview
  • Product List